Urban appeal of city centre homes

Urban living is back in fashion after a brief move away from cities during the pandemic

Angion Biomedica Corp. (ANGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.5000

+0.1800

(+13.64%)

At close: 04:00PM EDT

1.6000

+0.10

(+6.67%)

After hours:

07:38PM EDT

Loading interactive chart…

Zacks
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease
Aerie Pharmaceutials (AERI) doses the first patient in a phase III study on its investigational TRMP8 agonist drug for the treatment of dry eye disease.
Zacks
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Zacks
The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma
Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma are part of Zacks top Analyst Blog